B of A Securities Downgrades Omega Healthcare Invts to Neutral, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Joshua Dennerlein downgraded Omega Healthcare Investors (OHI) from Buy to Neutral and reduced the price target from $33 to $31.
January 16, 2024 | 5:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Omega Healthcare Investors was downgraded by B of A Securities from Buy to Neutral with a price target decrease from $33 to $31.
Downgrades by analysts can lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The reduction in the price target further supports the expectation of a lower valuation.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100